Thoracic-Surgery Unit, Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Padua, Italy.
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Ann Thorac Surg. 2021 Aug;112(2):450-458. doi: 10.1016/j.athoracsur.2020.08.035. Epub 2020 Oct 20.
Total lung-sparing tracheobronchial sleeve resections are a step forward in the treatment of low-grade bronchial tumors in which minimal resection margins are required to achieve complete control of the disease.
This study retrospectively collected data on patients who underwent total lung-sparing procedures for low-grade tracheobronchial tumors at 2 thoracic surgical centers from January 1984 to October 2019.
The study included 98 patients, 46 -female (47%) and 52 -male (53%), with a median age of 39 years (range, 7 to 70 years). Thirty-four patients underwent operative endoscopy before surgery (32 had laser treatment, and 2 had endobronchial stenting). The surgical resections were as follows: 9 (9%), tracheal carina; 18 (18%), second carina; 31 (32%), left main bronchi; 25 (26%), right main bronchi; and 15 (15%), intermediate bronchus. The median length of the resected bronchus was 2.2 cm. The median postoperative in-hospital stay was 8 days, and no perioperative mortality was observed. Postoperative complications were recorded in 26-patients (27%). The final histologic classification was as follows: 37 typical carcinoids (38%); 10 atypical carcinoids (10%); 29 adenoid cystic carcinomas (30%); 15 mucoepidermoid carcinomas (15%); 6 inflammatory myofibroblastic tumors (6%); and 1 glomic tumor (1%). Twenty-two patients had positive resection margins and underwent adjuvant radiotherapy. Three patients with adenoid cystic carcinoma had recurrences (1 local and 2 systemic). After a median follow-up time of 54.5 months (range, 4 to 360 months), the overall actuarial 5-year survival was 97%.
Total lung-sparing tracheobronchial sleeve resection for low-grade malignant disease requires advanced surgical skills, but the hospital morbidity and mortality are very low. This technique is adequate and safe for highly selected patients with low-grade endobronchial malignant diseases, and its use should be encouraged in experienced centers.
全肺保留性气管支气管袖状切除术是治疗低度支气管肿瘤的一项进步,这种手术需要最小的切除范围,以达到完全控制疾病的目的。
本研究回顾性收集了 1984 年 1 月至 2019 年 10 月在 2 个胸外科中心接受全肺保留性手术治疗低度气管支气管肿瘤的患者数据。
研究纳入了 98 例患者,其中女性 46 例(47%),男性 52 例(53%),中位年龄为 39 岁(范围 7 至 70 岁)。34 例患者在术前接受了手术内镜检查(32 例行激光治疗,2 例行支气管内支架置入术)。手术切除部位如下:9 例(9%)为气管隆嵴;18 例(18%)为第二隆嵴;31 例(32%)为左主支气管;25 例(26%)为右主支气管;15 例(15%)为中间支气管。切除支气管的中位长度为 2.2cm。中位术后住院时间为 8 天,无围手术期死亡。26 例患者(27%)发生术后并发症。最终的组织学分类如下:37 例典型类癌(38%);10 例非典型类癌(10%);29 例腺样囊性癌(30%);15 例黏液表皮样癌(15%);6 例炎症性肌纤维母细胞瘤(6%);1 例血管球瘤(1%)。22 例患者切缘阳性,行辅助放疗。3 例腺样囊性癌患者复发(1 例局部复发,2 例全身复发)。中位随访时间为 54.5 个月(范围 4 至 360 个月),总体 5 年生存率为 97%。
全肺保留性气管支气管袖状切除术治疗低度恶性疾病需要较高的手术技能,但住院发病率和死亡率非常低。对于低度支气管内恶性疾病的高度选择患者,该技术是足够且安全的,应在有经验的中心推广使用。